Compare HELP & WEYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HELP | WEYS |
|---|---|---|
| Founded | 2019 | 1906 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Apparel |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 574.7M | 486.0M |
| IPO Year | 2020 | 1995 |
| Metric | HELP | WEYS |
|---|---|---|
| Price | $6.54 | $51.68 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 11 | 0 |
| Target Price | ★ $46.17 | N/A |
| AVG Volume (30 Days) | ★ 1.8M | 36.9K |
| Earning Date | 11-16-2026 | 11-03-2026 |
| Dividend Yield | N/A | ★ 2.19% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 3.23 |
| Revenue | N/A | ★ $276,169,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $15.87 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $3.76 | $28.69 |
| 52 Week High | $15.15 | $68.39 |
| Indicator | HELP | WEYS |
|---|---|---|
| Relative Strength Index (RSI) | 26.96 | 39.91 |
| Support Level | $4.41 | $50.05 |
| Resistance Level | $8.50 | $53.83 |
| Average True Range (ATR) | 0.95 | 3.52 |
| MACD | -0.20 | -0.99 |
| Stochastic Oscillator | 5.76 | 5.25 |
Helus Pharma Inc, the commercial operating name of Cybin Inc, is a clinical-stage pharmaceutical company focused on developing proprietary neuroactive compounds, referred to as NSAs, which are synthetic molecules designed to target serotonin pathways. The company's programs are aimed at treating mental health conditions such as depression and anxiety. Its pipeline includes HLP003, which is in clinical development for the adjunctive treatment of depressive disorder, and HLP004, which is in clinical development for generalized anxiety disorder. The company also conducts research on additional investigational compounds.
Weyco Group Inc is a company, engaged in the manufacturing, designing, and distribution of footwear. The company designs and markets footwear for men, women, and children. It markets its apparel, accessories, and footwear under the brand names of Florsheim, Nunn Bush, Stacy Adams, BOGS, Rafters, and Forsake. The company organizes its business into two segments; the North American wholesale operations and the North American retail operations. The majority of the company's revenue is generated from the wholesale segment under which its products are sold to footwear, department, and specialty stores, as well as e-commerce retailers. The company has operational footprints in the United States which generates key revenue, Canada, South Africa, and Australia.